Kenvue (KVUE) Stock Price

Kenvue Price

NYSE·CLOSED
17.53
​
Market closed

Revenue has compounded at 0.9% per year over the past 6 years to 15.12 B USD. Earnings per share have grown at 0.1% per year over the last 6 years. Kenvue's net margin stands at 9.7%, down from 13.8% several years earlier. Kenvue currently offers a dividend yield of about 4.71%. The payout ratio is around 108% of earnings. The dividend has grown at 43.6% per year over the past 2 years. Analysts set a median price target of 19.50 USD, implying 11.2% above the current price. Of 20 analysts, 6 rate the stock a buy — an overall Hold consensus.

Kenvue stock price

Access this data via the Eulerpool API

Kenvue business model & stock analysis

Kenvue, Inc. is a consumer health company. The company is headquartered in Skillman, New Jersey and currently employs 22,200 full-time employees. The company went IPO on 2023-05-04. The firm operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment product categories include cough, cold and allergy; pain care; and other self-care (digestive health, smoking cessation and other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health and wound care). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. Its network includes 114 distribution centers and 38 customer service centers across all its regions.

Frequently asked questions about Kenvue

Analysts currently set an average price target of 19.50 USD for the Kenvue stock (median: 19.50 USD), implying +11.2 % versus the latest price. The consensus is based on 20 analyst ratings.

20 analysts currently rate the Kenvue stock: 6 recommend buying, 14 holding and 0 selling. For 2026, analysts expect Kenvue to generate revenue of 15.60 B USD and earnings per share of 1.17 USD.

Converted at the current exchange rate, the Kenvue share trades at 15.65 EUR (17.53 USD).

The Kenvue share (KVUE) is listed on 5 stock exchanges, including: NYSE (KVUE), Frankfurt (J4D.F), München (J4D.MU), Düsseldorf (J4D.DU), Hamburg (J4D.HM).

The expected revenue of Kenvue is 15.60 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Kenvue is 2.25 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Kenvue is currently 14.94. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Kenvue stock.

The price-to-sales ratio (P/S) of Kenvue is currently 2.16. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Kenvue stock.

The Eulerpool Quality Score for Kenvue is 1/10.

The ISIN of Kenvue is US49177J1025. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Kenvue is A3EEHU. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Kenvue is KVUE. The ticker symbol is used to trade Kenvue shares on the stock exchange.

Fair ValueTerminal
16.83 USD
Over-/UndervaluationTerminal
Fairly valued
Industry
Personal Care Products
Number of shares
Employees
Revenue per Employee
687,454.55 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Currency
USD
Initial public offering
May 4, 2023
ISIN
US49177J1025
Cusip
49177J102
Market capitalization
33.59 B USDLarge Cap
52-Week Range
PEG
5.79
P/E ratio
P/Ee 2026
14.91
P/Ee 2027
14.07
P/Ee 2028
13.18
P/Ee 2029
12.27
P/Ee 2030
12.28
P/S
P/Se
2.16
EV/EBIT
15.13
P/B Ratio
3.12
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
7.67 %
Dividend
Dividend yield
4.71 %
Est. Dividend Yield
4.76 %
Payout Ratio
107.76 %
Dividend growth Ø5Y
—
Dividend payments per year
4
Dividend paid since
3 years
Dividend not reduced since
3 years
Dividend increased since
3 years
Dividend withholding tax
30.00 %
Last updated Oct 8, 2026, 6:29 PM

Kenvue Peer Group

Kenvue Ticker

DÜSSELDORF · J4D.DUFRANKFURT · J4D.FHAMBURG · J4D.HMMUNICH · J4D.MUNEW YORK · KVUE

Kenvue FIGI

KVUE:US · BBG01C79X561KVUE:UA · BBG01C79X570KVUE:UC · BBG01C79X589KVUE:UN · BBG01C79X5B5KVUE:UP · BBG01C79X5C4KVUE:UB · BBG01C79X5F1KVUE:UT · BBG01C79X5G0KVUE:UM · BBG01C79X5H9KVUE:UX · BBG01C79X5J7KVUE:UD · BBG01C79X5P0KVUE:UF · BBG01C79X5S7KVUE:VY · BBG01C79X5T6

All fundamentals and in-depth analysis of Kenvue

Our stock analysis for Kenvue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kenvue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.